A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Adrienne H Long, Waleed M Haso, Jack F Shern, Kelsey M Wanhainen, Meera Murgai, Maria Ingaramo, Jillian P Smith, Alec J Walker, M Eric Kohler, Vikas R Venkateshwara, Rosandra N Kaplan, George H Patterson, Terry J Fry, Rimas J Orentas, Crystal L Mackall. Nat Med 2015
Times Cited: 668




List of shared articles



Times cited


Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment.
Norihiro Watanabe, Mary Kathryn McKenna, Amanda Rosewell Shaw, Masataka Suzuki. Mol Ther 2021
7

Anti-CD19 CAR-T cells: Digging in the dark side of the golden therapy.
Stella Bouziana, Dimitrios Bouzianas. Crit Rev Oncol Hematol 2021
2

A metabolic switch to memory CAR T cells: Implications for cancer treatment.
Hosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, John M Pawelek, Jamshid Hadjati, Christine E Brown, Hamid R Mirzaei. Cancer Lett 2021
2

Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.
Zhenyu Dai, Xuelian Hu, Xiangyin Jia, Jianwei Liu, Yongkun Yang, Panpan Niu, Guang Hu, Taochao Tan, Jianfeng Zhou. J Cell Physiol 2021
1

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma.
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri, Michael D Hogarty, David M Barrett, Hiroyuki Shimada, Shahab Asgharzadeh. Nat Commun 2021
6

Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments.
Xinjie Xu, Shengkang Huang, Xinyi Xiao, Qihang Sun, Xiaoqian Liang, Sifei Chen, Zijing Zhao, Zhaochang Huo, Sanfang Tu, Yuhua Li. Front Immunol 2021
2

Shaping Functional Avidity of CAR T Cells: Affinity, Avidity, and Antigen Density That Regulate Response.
Raanan Greenman, Yoav Pizem, Maya Haus-Cohen, Alona Goor, Guy Horev, Galit Denkberg, Keren Sinik, Yael Elbaz, Vered Bronner, Anat Globerson Levin,[...]. Mol Cancer Ther 2021
1

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies.
Lu Tang, Yinqiang Zhang, Yu Hu, Heng Mei. Biomed Res Int 2021
5

Chimeric Antigen Receptor Design Today and Tomorrow.
Justin C Boucher, Marco L Davila. Cancer J 2021
0

CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities.
Maryam Akhoundi, Mahsa Mohammadi, Seyedeh Saeideh Sahraei, Mohsen Sheykhhasan, Nashmin Fayazi. Cell Oncol (Dordr) 2021
2

Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models.
Dina Schneider, Ying Xiong, Darong Wu, Peirong Hu, Leah Alabanza, Brittany Steimle, Hasan Mahmud, Kim Anthony-Gonda, Winfried Krueger, Zhongyu Zhu,[...]. Sci Transl Med 2021
8

Robust CAR-T memory formation and function via hematopoietic stem cell delivery.
Anjie Zhen, Mayra A Carrillo, Wenli Mu, Valerie Rezek, Heather Martin, Philip Hamid, Irvin S Y Chen, Otto O Yang, Jerome A Zack, Scott G Kitchen. PLoS Pathog 2021
1

Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Guillermo O Rangel Rivera, Hannah M Knochelmann, Connor J Dwyer, Aubrey S Smith, Megan M Wyatt, Amalia M Rivera-Reyes, Jessica E Thaxton, Chrystal M Paulos. Front Immunol 2021
3

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
Ying Gong, Roel G J Klein Wolterink, Jianxiang Wang, Gerard M J Bos, Wilfred T V Germeraad. J Hematol Oncol 2021
2

Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
Zhiliang Bai, Stefan Lundh, Dongjoo Kim, Steven Woodhouse, David M Barrett, Regina M Myers, Stephan A Grupp, Marcela V Maus, Carl H June, Pablo G Camara,[...]. J Immunother Cancer 2021
1

Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Stephanie J Si Lim, Stephen A Grupp, Amanda M DiNofia. Pediatr Blood Cancer 2021
0


A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

The therapeutic implications of immunosuppressive tumor aerobic glycolysis.
Bradley I Reinfeld, W Kimryn Rathmell, Tae Kon Kim, Jeffrey C Rathmell. Cell Mol Immunol 2021
0

[Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Marie Thérèse Rubio, Pauline Varlet, Vincent Allain, Caroline Ballot, Alexis Cuffel, Marina Deschamps, Christophe Ferrand, Jacques Foguenne, Edouard Forcade, Anne Huynh,[...]. Bull Cancer 2021
0

Immunotherapies in Non-Hodgkin's Lymphoma.
Christine Bezombes, Patricia Pérez-Galán. Cancers (Basel) 2021
0

Mitochondria as Playmakers of CAR T-cell Fate and Longevity.
Hosein Rostamian, Mohammad Khakpoor-Koosheh, Keyvan Fallah-Mehrjardi, Hamid R Mirzaei, Christine E Brown. Cancer Immunol Res 2021
0

Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Niels W C J van de Donk, Maria Themeli, Saad Z Usmani. Blood Cancer Discov 2021
1


Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells.
Hongxia Wang, Liyan Wang, Yanning Li, Guangqi Li, Xiaochun Zhang, Dan Jiang, Yanting Zhang, Liyuan Liu, Yuankui Chu, Guangxian Xu. Cancer Cell Int 2021
0

Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function.
Alexander I Salter, Anusha Rajan, Jacob J Kennedy, Richard G Ivey, Sarah A Shelby, Isabel Leung, Megan L Templeton, Vishaka Muhunthan, Valentin Voillet, Daniel Sommermeyer,[...]. Sci Signal 2021
0

Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors.
Brian Belmontes, Deepali V Sawant, Wendy Zhong, Hong Tan, Anupurna Kaul, Famke Aeffner, Sarah A O'Brien, Matthew Chun, Rajkumar Noubade, Jason Eng,[...]. Sci Transl Med 2021
0

PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Yamin Jie, Guijun Liu, Lina Feng, Ying Li, Mingyan E, Liangliang Wu, Yinyin Li, Guanghua Rong, Yongwu Li, Huafeng Wei,[...]. Front Immunol 2021
0

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy.
Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean-Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard,[...]. Cancers (Basel) 2021
0

Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh. Best Pract Res Clin Haematol 2021
0

Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
0

Reducing Hinge Flexibility of CAR-T Cells Prolongs Survival In Vivo With Low Cytokines Release.
Ang Zhang, Yao Sun, Jie Du, Yansheng Dong, Honggang Pang, Lei Ma, Shaoyan Si, Zhong Zhang, Mingyi He, Yang Yue,[...]. Front Immunol 2021
0

Determinants of response and resistance to CAR T cell therapy.
Stefanie Lesch, Mohamed-Reda Benmebarek, Bruno L Cadilha, Stefan Stoiber, Marion Subklewe, Stefan Endres, Sebastian Kobold. Semin Cancer Biol 2020
23

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.
Chuang Sun, Peishun Shou, Hongwei Du, Koichi Hirabayashi, Yuhui Chen, Laura E Herring, Sarah Ahn, Yang Xu, Kyogo Suzuki, Guangming Li,[...]. Cancer Cell 2020
28

Rapid and Effective Generation of Nanobody Based CARs using PCR and Gibson Assembly.
Stijn De Munter, Alexander Van Parys, Layla Bral, Joline Ingels, Glenn Goetgeluk, Sarah Bonte, Melissa Pille, Lore Billiet, Karin Weening, Annick Verhee,[...]. Int J Mol Sci 2020
5

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.
Sonia Guedan, Aviv Madar, Victoria Casado-Medrano, Carolyn Shaw, Anna Wing, Fang Liu, Regina M Young, Carl H June, Avery D Posey. J Clin Invest 2020
39

A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells.
Darin Bloemberg, Tina Nguyen, Susanne MacLean, Ahmed Zafer, Christine Gadoury, Komal Gurnani, Anindita Chattopadhyay, Josée Ash, Julie Lippens, Doreen Harcus,[...]. Mol Ther Methods Clin Dev 2020
6

Adoptive T-cell therapy for HBV-associated HCC and HBV infection.
Anthony T Tan, Sophia Schreiber. Antiviral Res 2020
8

Prospects and challenges for use of CAR T cell therapies in solid tumors.
Sneha Ramakrishna, Valentin Barsan, Crystal Mackall. Expert Opin Biol Ther 2020
11